Skip to search formSkip to main contentSkip to account menu

ciraparantag

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

PER977

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Faculty Opinions recommendation of Single-dose ciraparantag safely and completely reverses anticoagulant effects of edoxaban.
  • J. Biller
  • Faculty Opinions – Post-Publication Peer Review…
  • 2019
  • Corpus ID: 88398350
Review
2017
Review
2017
Role of agents for reversing the effects of target-specific oral anticoagulants.
PURPOSE The available clinical data on target-specific oral anticoagulant (TSOAC) reversal agents that are currently in… 
Review
2016
Review
2016
Discontinuation and Management of Direct-Acting Anticoagulants for Emergency Procedures.
2016
2016
Vitamin K antagonists, direct oral anticoagulants, and the rationale for reversal agents.
Until late 2010, the vitamin K antagonist warfarin was the only oral anticoagulant approved in the United States for the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)